Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
JCI Insight|March 25, 2021
PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancerLucia Liotta, Sebastian Lange, H Carlo Maurer, et al.
EMBO Molecular Medicine|February 1, 2014
Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injurySabyasachi Bhattacharya, Kanstantsin V Katlinski, Maximilian Reichert, et al.
Gastroenterology|October 2, 2020
Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer BiologyKarin Feldmann, Carlo Maurer, Katja Peschke, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2025
Navigating rare cancer care: Patient-reported insights into patient journeys, time to diagnosis, decision-making and care coordination from a national cross-sectional study in GermanyLaura Oestreich, Friederike Mumm, Theresia Pichler, et al.
JCI Insight|May 22, 2020
Loss of Wasl improves pancreatic cancer outcomeAna Hidalgo-Sastre, Judit Desztics, Zahra Dantes, et al.
Bioorganic Chemistry|November 28, 2021
A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancerSvenja Lier, Andreas Sellmer, Felix Orben, et al.
Cancer Research|December 14, 2021
HDAC2 Facilitates Pancreatic Cancer MetastasisLukas Krauß, Bettina C Urban, Sieglinde Hastreiter, et al.
Developmental Cell|June 20, 2018
Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic CancerMaximilian Reichert, Basil Bakir, Leticia Moreira, et al.
Gut|May 12, 2025
Activation of RAS/MEK/ERK signalling drives biliary differentiation in primary liver cancerThomas Rösner, Carina Rupp, Christian Lechler, et al.
EMBO Molecular Medicine|March 5, 2021
Combination therapies induce cancer cell death through the integrated stress response and disturbed pyrimidine metabolismGoetz Hartleben, Kenji Schorpp, Yun Kwon, et al.
Pageof 9